Impact of metformin on the progression of MGUS to multiple myeloma
- PMID: 27701912
- PMCID: PMC5371023
- DOI: 10.1080/10428194.2016.1236375
Impact of metformin on the progression of MGUS to multiple myeloma
Similar articles
-
Association between metformin use and progression of monoclonal gammopathy of undetermined significance to multiple myeloma in US veterans with diabetes mellitus: a population-based retrospective cohort study.Lancet Haematol. 2015 Jan;2(1):e30-6. doi: 10.1016/S2352-3026(14)00037-4. Lancet Haematol. 2015. PMID: 26034780 Free PMC article.
-
Clinical characteristics and outcomes in biclonal gammopathies.Am J Hematol. 2016 May;91(5):473-5. doi: 10.1002/ajh.24319. Epub 2016 Apr 6. Am J Hematol. 2016. PMID: 26840395 Free PMC article.
-
[Retrospective analysis of progression to multiple myeloma or related disorders in 114 patients with monoclonal gammopathy of undetermined significance in a single institute].Rinsho Ketsueki. 2012 Mar;53(3):303-9. Rinsho Ketsueki. 2012. PMID: 22499046 Japanese.
-
[Monoclonal gammopathy of undetermined significance--potential risk factor of multiple myeloma].Przegl Lek. 2012;69(5):194-6. Przegl Lek. 2012. PMID: 23050415 Review. Polish.
-
MGUS and smoldering myeloma: the most prevalent of plasma cell dyscrasias.Oncology (Williston Park). 2011 Jun;25(7):594, 596. Oncology (Williston Park). 2011. PMID: 21888257 Review. No abstract available.
Cited by
-
Artificial intelligence-enabled screening strategy for drug repurposing in monoclonal gammopathy of undetermined significance.Blood Cancer J. 2023 Feb 17;13(1):28. doi: 10.1038/s41408-023-00798-7. Blood Cancer J. 2023. PMID: 36797276 Free PMC article.
-
Unraveling Obesity and Multiple Myeloma: Insights from Epidemiology and Molecular Mechanisms.Curr Obes Rep. 2025 Jun 5;14(1):52. doi: 10.1007/s13679-025-00644-w. Curr Obes Rep. 2025. PMID: 40468124 Free PMC article. Review.
-
Discovering Potential in Non-Cancer Medications: A Promising Breakthrough for Multiple Myeloma Patients.Cancers (Basel). 2024 Jun 28;16(13):2381. doi: 10.3390/cancers16132381. Cancers (Basel). 2024. PMID: 39001443 Free PMC article. Review.
-
It is worth the weight: obesity and the transition from monoclonal gammopathy of undetermined significance to multiple myeloma.Blood Adv. 2023 Sep 26;7(18):5510-5523. doi: 10.1182/bloodadvances.2023010822. Blood Adv. 2023. PMID: 37493975 Free PMC article. Review.
-
Influence of metformin on HIF-1 pathway in multiple myeloma.Pharmacol Rep. 2020 Oct;72(5):1407-1417. doi: 10.1007/s43440-020-00142-x. Epub 2020 Jul 27. Pharmacol Rep. 2020. PMID: 32715434 Free PMC article.
References
-
- Kyle RA, Therneau TM, Rajkumar SV, et al. Prevalence of monoclonal gammopathy of undetermined significance. NEJM. 2006;354:1362–1369. - PubMed
-
- Röllig C, Knop S, Bornhäuser M. Multiple myeloma. Lancet. 2015;385:2197–2208. - PubMed
-
- Kyle RA, Therneau TM, Rajkumar SV, et al. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. NEJM. 2002;346:564–569. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical